Treatment of pulmonary infections.
D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006192:Haemophilus Infections / Q000188:drug therapy; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D009175:Mycoplasma Infections / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D011024:Pneumonia, Viral / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D010406:Penicillins